SunWay Biotech Co (ROCO:1271) Accounts Payable: NT$26.4 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1271 SunWay Biotech Co Ltd ROCO:1271
92 GF Score
Price NT$58.50
GF Value NT$70.86
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is SunWay Biotech Co Accounts Payable?

SunWay Biotech Co ROCO:1271 -0.51% 92 Accounts Payable is NT$26.4 Mil as of Dec. 2025. GuruFocus rates ROCO:1271 with a GF Score™ of 92/100 and a GF Value™ of NT$70.86 (Modestly Undervalued). The stock has 7 warning signs investors should review.

SunWay Biotech Co's Accounts Payable for the quarter that ended in Dec. 2025 was NT$26.4 Mil.

SunWay Biotech Co's quarterly Accounts Payable declined from Dec. 2024 (NT$45.7 Mil) to Jun. 2025 (NT$41.7 Mil) and declined from Jun. 2025 (NT$41.7 Mil) to Dec. 2025 (NT$26.4 Mil).

SunWay Biotech Co's annual Accounts Payable increased from Dec. 2023 (NT$19.5 Mil) to Dec. 2024 (NT$45.7 Mil) but then declined from Dec. 2024 (NT$45.7 Mil) to Dec. 2025 (NT$26.4 Mil).

SunWay Biotech Co Accounts Payable Related Terms

SunWay Biotech Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for SunWay Biotech Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SunWay Biotech Co Accounts Payable Chart

SunWay Biotech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.42 55.18 19.53 45.68 26.41

SunWay Biotech Co Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.53 42.37 45.68 41.74 26.41
ROCO:1271
92GF Score
SunWay Biotech Co Ltd ROCO:1271
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SunWay Biotech Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NT$26.4 Mil mean?
SunWay Biotech Co (ROCO:1271) has a Accounts Payable of NT$26.4 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on SunWay Biotech Co and its competitors.
Is SunWay Biotech Co's Accounts Payable too high?
SunWay Biotech Co's current Accounts Payable is NT$26.4 Mil. Overall, SunWay Biotech Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SunWay Biotech Co's Accounts Payable compare to KHC and GIS?
SunWay Biotech Co's Accounts Payable of NT$26.4 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Consumer Packaged Goods company?
A good Accounts Payable depends on the Consumer Packaged Goods industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on SunWay Biotech Co and its competitors. SunWay Biotech Co's current Accounts Payable is NT$26.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SunWay Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, SunWay Biotech Co (ROCO:1271) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$70.86, compared to a current price of NT$58.50 — trading 17.4% below its estimated fair value. The current Accounts Payable is NT$26.4 Mil. SunWay Biotech Co's overall GF Score™ is 92/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For SunWay Biotech Co (ROCO:1271), the current Accounts Payable is NT$26.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SunWay Biotech Co (ROCO:1271) Overvalued in 2026?

Based on GuruFocus' analysis, SunWay Biotech Co stock appears to be undervalued. The current stock price of NT$58.50 is trading 17.4% below its estimated GF Value™ of NT$70.86. GuruFocus considers SunWay Biotech Co to be Modestly Undervalued.

Key valuation signals for ROCO:1271:

  • Accounts Payable: NT$26.4 Mil
  • GF Value™: NT$70.86 vs. price of NT$58.50 (17.4% below fair value)
  • GF Score™: 92/100 with 7 warning signs

No single metric tells the full story. See the ROCO:1271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SunWay Biotech Co Business Description

Address No. 139, Xing’ai Road, Neihu District, Taipei, TWN, 11494
SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.
92GF Score

Get the complete analysis for ROCO:1271

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$58.50
Price
NT$70.86
GF Value